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The mammalian homologue, class O of forkhead box
transcription factors (FoxO) comprises four members (Fuku-
naga et al. 2005): FoxO1, FoxO3, FoxO4 and FoxO6, and of
these FoxO1, FoxO3 and FoxO6 expression has been
detected in the brain (Furuyama et al. 2000; Biggs et al.
2001; Hoekman et al. 2006). FoxO binds to a core DNA
consensus sequence, referred to as the Forkhead-response
element (FHRE) to increase expression of pro-apoptotic
genes (Furuyama et al. 2000). While FoxO activity is
essential to normal programmed cell death during develop-
ment, it has also been implicated in initiating apoptosis in
cases of brain injury and in the progression of neurodegen-
erative disorders in the mature nervous system (Chong et al.
2005; Fukunaga et al. 2005; Su et al. 2009). There are
several stressful triggers that stimulate nuclear translocation
of FoxO in neurones including trophic factor withdrawal
(Gilley et al. 2003; Barthelemy et al. 2004; Biswas et al.
2007), oxidative stress (Lehtinen et al. 2006), ischaemia
(Fukunaga et al. 2005) and the activation of extrasynaptic
NMDA receptors (Dick and Bading 2010). FoxO subse-
quently increases expression of genes encoding death
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Abstract
The Forkhead transcription factor, FoxO3a induces genomic
death responses in neurones following translocation from the
cytosol to the nucleus. Nuclear translocation of FoxO3a is
triggered by trophic factor withdrawal, oxidative stress and the
stimulation of extrasynaptic NMDA receptors. Receptor acti-
vation of phosphatidylinositol 3-kinase (PI3K)–Akt signalling
pathways retains FoxO3a in the cytoplasm, thereby inhibiting
the transcriptional activation of death-promoting genes. We
hypothesized that phenolic antioxidants such as tert-Butylhy-
droquinone (tBHQ), which is known to stimulate PI3K–Akt
signalling, would inhibit FoxO3a translocation and activity.
Treatment of cultured cortical neurones with NMDA increased
the nuclear localization of FoxO3a, reduced the phosphory-
lation of FoxO3a, increased caspase activity and up-regulated
Fas ligand expression. In contrast the phenolic antioxidant,
tBHQ, caused retention of FoxO3a in the cytosol coincident
with enhanced PI3K- dependent phosphorylation of FoxO3a.
tBHQ-induced nuclear exclusion of FoxO3a was associated
with reduced FoxO-mediated transcriptional activity. Exposure
of neurones to tBHQ inhibited NMDA-induced nuclear trans-
location of FoxO3a, prevented NMDA-induced up-regulation
of FoxO-mediated transcriptional activity, blocked caspase
activation and protected neurones from NMDA-induced ex-
citotoxic death. Collectively, these data suggest that phenolic
antioxidants such as tBHQ oppose stress-induced activation
of FoxO3a and therefore have potential neuroprotective utility
in neurodegeneration.
Keywords: caspase, dietary antioxidant, Fas ligand, motor
neuron, NMDA receptor, PI3-kinase.
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proteins such as Bim (Bcl-2-interacting mediator of cell
death) and Fas ligand (Brunet et al. 1999; Gilley et al. 2003;
Barthelemy et al. 2004; Biswas et al. 2007).
Transcriptional activity of FoxO is partly determined by its
subcellular location, which in turn is regulated by phosphor-
ylation of three key residues at Thr-24, Ser-256 and Ser-319
(Nakae et al. 1999) lying downstream of PI3K–Akt signal-
ling. FoxO3a phosphorylation at these sites causes it to be
exported from the nucleus and retained in the cytoplasm in a
Crm-1- and 14-3-3-dependent manner, thus rendering
FoxO3a incapable of transcribing target apoptotic genes
(Brunet et al. 1999). Neuroprotective phenolic antioxidants
such as tBHQ and dietary flavonoids stimulate PI3K–Akt
signalling and up-regulate Nrf2-dependent antioxidant re-
sponse element activity (Johnson et al. 2002; Kraft et al.
2004; Schroeter et al. 2007; Bahia et al. 2008; Arredondo
et al. 2010; Williams and Spencer 2012), but it is not known
if they also inhibit FoxO3a activity to exert neuroprotective
effects in neurones. The aim of this study, therefore, was to
establish a link between FoxO3a activity and NMDA
receptor-evoked neuronal cell death and to determine if
phenolic antioxidants such as tBHQ could exert neuropro-
tection by opposing activation of this pro-apoptotic pathway.
The work described here demonstrates that exposure of
neurones to tBHQ inhibited NMDA-induced nuclear trans-
location of FoxO3a, prevented NMDA-induced up-regula-
tion of FoxO-mediated transcriptional activity, blocked




NMDA and kainate were purchased from Tocris Bioscience
(Bristol, UK). Tert-butyl hydroquinone (tBHQ) was purchased from
Sigma-Aldrich (Poole, UK) and wortmannin from Calbiochem
Corporation (La Jolla, CA, USA). Primary antibodies used were
anti-FoxO3a and anti-phospho FoxO3a (Cell Signaling Technology,
Danvers, MA, USA), anti-Fas ligand from Millipore (Watford, UK),
anti-activated caspase 3 (Asp175) from New England Biolabs
(Hitchin, UK) anti-beta Tubulin from Abcam (Cambridge, UK),
anti-SMI-32R from Covance (Princeton, NJ, USA). Fluorescently
labelled secondary antibodies, chicken anti-rabbit Alexa Fluor 488
and goat anti-mouse Alexa Fluor 568 were obtained from
Invitrogen (Paisley, UK) and horseradish peroxidase-conjugated
goat anti-rabbit antibody from Millipore. Cells were mounted in
Mowiol mounting medium with Hoechst 33342 (Calbiochem
Corporation). The Dual-Glo luciferase assay system, pGL3 basic,
pRL-TK renilla and restriction enzymes were from Promega
(Madison, WI, USA). Cell culture reagents were obtained from
Invitrogen and all other reagents from Sigma-Aldrich or Merck.
Cell culture
Animals were maintained and used according to the U.K. Animals
(Scientific Procedures) Act, 1986 and institutional ethical approval.
Animals were killed using cervical dislocation (Schedule 1
procedure) according to Home Office guidelines. Primary cultured
neurones were prepared from 15 to 16-day-old Swiss mouse
embryos (NIH, Harlan, UK).
Cortical neurone culture
Cortical neurones were prepared essentially as described previously
(Hoey et al. 2009). Briefly, dissociated cortical neurones were
plated at 106 cells/mL into 24-well or six-well Nunc multiwell
plates (Nunc, Naperville, IL, USA) that had been coated previously
overnight with 15 lg/mL poly l-ornithine (Sigma-Aldrich). Neuro-
nes were seeded in phenol red-free Neurobasal B27-supplemented
medium (Invitrogen). Cells were cultured at 37C in a humidified
atmosphere of 95% air and 5% CO2 and experiments were
performed at 7–9 DIV. Neurones for immunocytochemistry were
cultured on 13-mm coverslips pre-coated with poly l-ornithine and
2 lg/mL laminin (Sigma-Aldrich).
Motor neurone culture
Motor neurones were prepared essentially as described previously
(Rainey-Smith et al. 2010). Spinal cords from embryos were
dissected out into phosphate-buffered saline containing 0.6%
glucose (PBS-gluc). The meninges were removed and the cords
cut into 5 mm3 pieces. Up to five cords in 1.5 mL PBS-gluc were
transferred to 15 mL centrifuge tubes. Trypsin (Invitrogen) was
added to a form a final concentration of 0.05%. The tubes were then
incubated at 37C for 10 min with gentle agitation every 2 min. The
supernatant was removed and the tissue resuspended in 1 mL L-15
medium containing 0.4% w/v bovine serum albumin (BSA) and
0.1 mg/mL DNase (D2; Worthington Biochemical Corporation,
Lakewood, NJ, USA). Tissue was then agitated for 3 min, triturated
and the supernatant transferred to a clean centrifuge tube. The pellet
was then resuspended in 1 mL L-15 containing 0.4% w/v BSA and
20 lg/mL Dnase and triturated again and the supernatant collected.
This process was repeated and the pooled supernatants were then
transferred onto a BSA cushion (1.5 mL of L-15 containing 4% w/v
BSA for the equivalent of five spinal cords) and spun for 5 min at
500 g in a Heraeus Biofuge Primo centrifuge (DJB Labcare, Bucks,
UK). The supernatant was then removed and the pellet resuspended
in 1 mL of culture medium consisting of phenol red-free Neuroba-
sal Medium supplemented with glutamine (2 mM), streptomycin
(100 lg/mL and penicillin 100 u/mL) and B27 diluted 1 : 50. This
was carefully layered onto 1.5 mL OptiPrep density gradient
medium (Axis-Shield UK, Cambridge, UK), diluted in L-15 to
contain 10.4% w/v iodixanol, in a 15 mL centrifuge tube. The cells
were then spun at 1000 g for 15 min with the centrifuge brake
switched off. Cells visible at the medium/OptiPrep interface were
collected and spun through a second BSA cushion for 5 min at
1500 rpm. Between 20 000 and 30 000 cells were resuspended per
millilitre of culture medium and strained through a 40 lm nylon
strainer (VWR International Ltd, Leicestershire, UK). Cells were
then plated out onto 13 mm coverslips coated with poly l-ornithine
(1 h at 20C) followed by a second incubation with culture medium
containing 2 lg/mL laminin (Sigma-Aldrich).
Plasmid constructs
pFHRE-luc: Synthesized oligos containing three repeats of the
insulin response element (as described by Guo et al. 1999) were
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obtained from Sigma-Aldrich. The element is shown underlined and
referred to as the Forkhead-Response Element or FHRE; forward:
5¢-CAAGCAAAACAAGCTAGCAAAACAAGCTAGCAAAACAAG
TA-3¢, reverse: 5¢- AGCTTACTTGTTTTGCTAGCTTGTTTTGCT
AGCTTGTTTTGCTTGGTAC-3¢). These were 5¢-phosphorylated and
annealed in a buffer consisting of 10 mM Tris–HCl, 50 mM NaCl and
1 mM EDTA for 5 min at 95C and then cooled to 20C. Annealed
oligos were ligated into the SacI and HindIII sites of the pGL3 basic
vector (Promega). pARE-luc: The pARE vector construction was
described in detail previously (Bahia et al. 2008). Briefly, synthesized
oligos were annealed as described above and ligated into the pGL3 basic
vector via the SacI and HindIII sites.
Transfection
Neurones in 24-well plates (5 · 105 cells/well) were transfected
using either pARE-luc or pFHRE-luc cis reporter plasmids along
with pRL-TK renilla. Transfections were performed using 0.5 lg
DNA/well and 0.5 lL LipofectAMINE 2000 (Invitrogen) according
to the manufacturer’s instructions).
Luciferase assay
Cells cultured in 24-well plates were treated by adding compounds
directly to the media, at the different time points indicated, before
the assay. The assay was performed according to the manufacturer’s
instructions (Promega). Briefly, medium was aspirated and cells left
in 20 lL Glo Lysis buffer for 10 min. Lysates were transferred to a
96-well luminometer plate (Sigma-Aldrich). Luciferase activities
produced by the luciferase reporter plasmids were measured by
adding 20 lL of luciferase substrate, then using a Veritas microplate
luminometer (Turner Biosystems Inc., Sunnyvale, CA, USA). All
treatments were performed in triplicate on three to four independent
cultures. Firefly luciferase activities were standardized to the
corresponding Renilla luciferase activities and statistical analyses
performed using one-way ANOVA and the Bonferroni post hoc test.
Immunoblotting
Cortical neurones were cultured in six-well Nunc plates, the
medium aspirated and the cells then lysed in 100 lL sodium
dodecyl sulphate–polyacrylamide gel electrophoresis sample buffer
(62.5 mM Tris, pH 6.8, 2% SDS, 5% 2-mercaptoethanol, 10%
glycerol and 0.0025% bromophenol blue) containing Complete,
Mini; Protease Inhibitor Cocktail Tablets from Roche Applied
Science (Burgess Hill, UK). Samples were then boiled for 5 min.
Thirty microlitres of the samples were resolved by 9% Tris-glycine
sodium dodecyl sulphate–polyacrylamide gel electrophoresis with
running buffer consisting of 25 mM TRIS-base, 192 mM glycine
and 0.1%SDS. After gel electrophoresis, proteins were transferred to
Hybond nitrocellulose (GE Healthcare, Piscataway, NJ, USA).
Immunodetection of phospho-FoxO3a and FoxO3a was performed
using primary polyclonal antibodies diluted at 1 : 200 and Fas
ligand at 1 : 1000. b-Tubulin levels were assessed as loading
controls at an antibody dilution of 1 : 10 000. The horseradish
peroxidase-conjugated goat-anti-rabbit IgG secondary antibody was
used at 1 : 10 000. Membranes were blocked for 30 min in TRIS-
buffered saline containing 4% milk powder and then washed
2 · 5 min in TBS containing 0.05% Tween-20. Primary antibodies
were made up in 1% milk powder in TBS containing 0.05% Tween-
20 and incubated overnight. Bands for the phospho-FoxO3a
(ser318/321) antibody were detected using the ECL plus system,
and all other antibodies using the ECL reagent (GE Healthcare)
followed by exposure to Hyperfilm ECL according to the manufac-
turer’s instructions (GE Healthcare) for 1–10 min to ensure signal
linearity and developed. Bands were analysed using Image-J
quantifier software (Wayne Rasband, NIH, MD, USA) and band
optical density expressed as a ratio relative to protein loading
control. Data were analysed using GraphPad Prism software
(GraphPad Software San Diego, CA, USA), and treatment group
compared to control using an unpaired t-test.
Immunocytochemistry
Treatments were performed by adding compounds directly to the
medium as described prior to fixing. Neurones were washed in
PBS (NaCl 136.9 mM, KCl 2.7 mM, Na2HPO4 9.2 mM, KH2PO4
1.8 mM, pH 7.2), then fixed in PBS containing 4% paraformal-
dehyde (Sigma-Aldrich) for 10 min. Cells were left in antibody
blocking solution [PBS containing 2% bovine serum albumin and
2% horse serum (Sigma-Aldrich) and 0.2% Triton X-100 (Merck)]
for 1 h. They were then incubated in antibody blocking solution
containing 1 : 200 dilution of anti-FoxO3a antibody (Santa Cruz
Biotechnologies, Santa Cruz, CA, USA) for 4 h. Cells were given
three 5-min washes in PBS containing 0.1% Tween 20 (Merck). A
second incubation using a chicken anti-rabbit Alexa Fluor 488
antibody (Invitrogen) was performed for 1 h. Cells were washed
again in PBS containing Tween-20, then incubated for 5 min in
PBS containing 10 lM Hoescht (2¢-(4-Ethoxyphenyl)-5-(4-methyl-
1-piperazinyl)-2,5¢-bi-1H-benzimidazole, 3HCl HOE 33342 from
Merck Chemicals Ltd, Hull, UK) and the coverslips mounted on
glass slides using Mowiol 4-88 hard-setting mounting medium
(Sigma). Staining results were viewed on a Zeiss apotome
microscope and recorded using Axiovision LE software (Carl
Zeiss Ltd., Hertfordshire, UK). For quantitative immunocytochem-
istry, cells were immunostained for FoxO3a and active caspase 3
following exposure to NMDA (50 lM) and/or tBHQ (30 lM) for
2–18 h. Three separate experiments were performed with six to
nine independent fields analysed for each condition at each time
point. Images were captured using fluorescence microscopy (Zeiss
Axioimager A1) and nuclei (Hoe 33342 positive) were manually
counted for each field. There were 50.0 ± 2.1 nuclei per field
(n = 138) and no significant differences between the nuclear
number with treatment or time. For activated caspase 3, the
number of nuclei surrounded by positive (+) or very strong (++)
cytoplasmic staining were counted and these two populations were
combined for analysis. For foxO3A, the number of nuclei with
positive staining in the nucleus were counted. Data were analysed
using GraphPad Prism software (GraphPad Software San Diego) at
each time point, using one-way ANOVA followed Bonferonni’s
Multiple Comparison test.
Results
NMDA causes pronounced dephosphorylation and
nuclear accumulation of FoxO3a
FoxO3a is regulated by phosphorylation at threonine32 (T1)
and serine253/315 residues (S1 and S2 respectively). Akt-
mediated phosphorylation of S1 is necessary for subsequent
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phosphorylation at the other sites (Nakae et al. 2000) and the
absence of S1 phosphorylation results in unmasking of the
FoxO3a nuclear localization signal (Fukunaga et al. 2005).
We first determined whether excitotoxic stimuli reduce
FoxO3a phosphorylation and drive nuclear accumulation of
FoxO3a in neurones. Cortical neurones were treated with
NMDA (50 lM) for 2 h, and FoxO3a phosphorylation and
FoxO3a translocation measured by immunoblotting and
immunocytochemistry. There was significant dephosphory-
lation of both the S1 (pFoxO3a ser253) and S2 (pFoxO3a
ser319/321) sites by 80% and 73%, respectively, relative to
total FoxO3a levels following exposure to NMDA (Fig 1b
and d) with no change in total levels of FoxO3a or b-tubulin
(Fig 1b). To determine whether NMDA-mediated dephos-
phorylation of FoxO3a resulted in the nuclear accumulation
of FoxO3a cells were probed with an anti-FoxO3a antibody
(Fig 1a). Under control conditions FoxO3a was distributed
throughout the cytoplasm of cortical neurones with some
diffuse staining evident in the nucleus (Fig 1a, Vehicle).
Following treatment with NMDA, FoxO3a staining was
almost exclusively nuclear (Fig 1a, NMDA). Kainate
induced a similar redistribution of FoxO3 from cytoplasm
to nucleus in cortical neurones (not shown) and also in motor
neurones (Figure S1).
We next examined Fas ligand (FasL) expression. FasL is a
member of the tumour necrosis factor (TNF) family, which
binds to the Fas receptor to initiate cell death via caspase
signalling cascades (e.g. Raoul et al. 1999). The FasL gene
has three FHRE (Brunet et al. 1999), and induction of FasL
by FoxO3A has been linked directly with neuronal death
(Barthelemy et al. 2004). To determine whether excitotoxic
signalling to FoxO3a resulted in increased expression of
FasL, immunoblotting was performed on lysates from




Fig. 1 NMDA inhibits FoxO3a phosphorylation, stimulates FoxO3a
nuclear translocation and up-regulates FasL. Cortical neurones were
treated with NMDA (50 lM) for 2 h, and FoxO3a phosphorylation and
FoxO3a translocation measured by immunoblotting (b, d) and immu-
nocytochemistry, respectively, (a) and FasL expression by immuno-
blotting only (c, e). Reduced dephosphorylation of both pFoxO3a
ser253 and pFoxO3a ser319/321 was evident following exposure to
NMDA (b, d) with no change in total levels of FoxO3a or b-tubulin, but
was associated with an increase in the levels of FasL (c, e). Blots
shown are representative of three independent experiments. (d) Data
presented as mean band intensity (mean ± SEM, n = 3) expressed as
pFoxO3a relative to total FoxO3a following exposure to Vehicle control
or NMDA (*p < 0.05, **p < 0.01). (e) Data presented as mean band
intensity (mean ± SEM, n = 3) expressed as FasL relative to b-tubulin
following exposure to Vehicle control or NMDA. To determine whether
NMDA-mediated dephosphorylation of FoxO3a resulted in the nuclear
accumulation of FoxO3a, cells were probed with an anti-FoxO3a
antibody [(a), left and right panels] and counter-stained with Hoe
33342 (right panel only) to label nuclei. Control represents staining
because of secondary antibody only. Under basal conditions, FoxO3a
was distributed throughout the cytoplasm of cortical neurones with
some diffuse staining evident in the nucleus (a, Vehicle). Following
treatment with NMDA, FoxO3a staining was almost exclusively nu-
clear (a, NMDA). Scale bar = 20 lm.
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protein could be detected under control conditions and
exposure to NMDA (50 lM, 2 h) caused a two-fold increase
in FasL (Fig 1c and e), suggesting that following transloca-
tion to the nucleus, FoxO3a up-regulates FasL in cortical
neurones.
tBHQ enhances phosphorylation and cytoplasmic
retention of FoxO3a
Having demonstrated that NMDA caused FoxO3a dephos-
phorylation and translocation to the nucleus, and induced
FasL, we wished to determine whether neuroprotective
phenolic antioxidants such as tBHQ could suppress FoxO3a
activation. It was not possible to demonstrate tBHQ inhibi-
tion of FasL expression as the basal levels in neurones were
too low (see Fig 1c). Cortical neurones were treated with
tBHQ (30 lM, 2 h), and FoxO3a phosphorylation and
FoxO3a translocation were measured by immunoblotting
and immunocytochemistry. tBHQ induced a clear trend
towards increased phosphorylation of both the S1 (pFoxO3a
ser253) and S2 (pFoxO3a ser319/321) sites by 149% and 151%,
respectively, relative to total foxO3a levels without changing
the total levels of FoxO3a or b-tubulin (Fig 2b). To
determine whether tBHQ-mediated phosphorylation of





Fig. 2 tert-Butylhydroquinone (tBHQ) stimulates FoxO3a phosphory-
lation and promotes cytosolic accumulation of FoxO3a. Cortical neu-
rones were treated with tBHQ (30 lM; 2 h), or wortmannin (150 nM;
2 h) and FoxO3a phosphorylation and FoxO3a translocation were
measured by immunoblotting and immunocytochemistry. tBHQ in-
creased the phosphorylation of both the S1 (pFoxO3a ser253) and S2
(pFoxO3a ser319/321) sites without changing the total levels of FoxO3a
or b-tubulin (b, d). Blots shown are representative of three indepen-
dent experiments. (d) Data presented as mean band intensity
(mean ± SEM, n = 3) expressed as pFoxO3a relative to total FoxO3a
following exposure to Vehicle control or tBHQ (*p < 0.05). Basal
(vehicle) and tBHQ-induced phosphorylation of pFoxO3a ser253 was
abolished by wortmannin (c). To determine whether tBHQ-induced
phosphorylation of FoxO3a affected the cellular distribution of FoxO3a
cells were probed with an anti-FoxO3a antibody [(a) left and right
panels] and counter-stained with Hoechst 33342 (right panel only) to
label nuclei. Under control conditions, FoxO3a was distributed
throughout the cytoplasm of cortical neurones with some low-level
diffuse staining evident in the nucleus (Fig 2, Vehicle). Following
treatment with tBHQ, FoxO3a staining was strongly cytoplasmic (Fig
2, tBHQ). This was particularly evident when compared with cells
treated with the PI3K inhibitor wortmannin, which resulted in pro-
nounced nuclear accumulation of FoxO3a (Fig 2, Wortmannin). Ima-
ges shown are representative of 100 individual cells. tBHQ caused
strong cytoplasmic accumulation of FoxO3a in 45% of stained cells.
Scale bar = 20 lm.
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were probed with an anti-FoxO3a antibody (Fig 2a). Under
control conditions, FoxO3a was distributed throughout the
cytoplasm of cortical neurones with some low-level diffuse
staining evident in the nucleus (Fig 2, Vehicle). Following
treatment with tBHQ, FoxO3a staining was strongly cyto-
plasmic (Fig 2, tBHQ). This was particularly evident when
compared with cells treated with the PI3K inhibitor,
wortmannin, which resulted in pronounced nuclear accumu-
lation of FoxO3a (Fig 2, Wortmannin). Wortmannin abol-
ished basal (vehicle) and tBHQ-mediated FoxO3a
phosphorylation (Fig 2c) and prevented tBHQ-induced cyto-
plasmic retention of FoxO3a (not shown).
tBHQ enhances antioxidant response element- and inhibits
forkhead-response element- activity in neurones
To ascertain whether the cytoplasmic retention of FoxO3a by
tBHQ is accompanied by a decrease in FoxO activity, a
luciferase assay was employed to examine changes in gene
expression downstream of a forkhead-response element
(FHRE-luc).To first define the experimental parameters, the
effect of tBHQ on ARE activity were examined, as ARE is a
well-characterized target of tBHQ (Kraft et al. 2004; Shih
et al. 2005; Bahia et al. 2008). tBHQ caused a concentra-
tion- (Fig 3a) and time-dependent (Fig 3b) increase in ARE-
mediated luciferase expression in neurones with maximal
effects observed at 30 lM tBHQ for 24 h. In contrast, tBHQ
caused a significant decrease in basal levels of FHRE activity
with maximum effects again observed at 30 lM tBHQ for
24 h (Fig 3c and d).
tBHQ inhibits NMDA-induced nuclear translocation of
FoxO3a and reduces caspase 3A activation
We next tested if the induction of apoptotic markers
following treatment with NMDA correlated with increase
in nuclear FoxO3a and also whether NMDA-dependent
caspase 3 activation and FoxO3a nuclear localization could
be abrogated by tBHQ. As expected, NMDA (50 lM, 2–
18 h) caused a time-dependent elevation in neurones
containing activated caspase 3 (Fig 4a, top panel). Relative
to vehicle controls, the number of cells containing activated
caspase after NMDA treatment were 291 ± 93%,
290 ± 82%, 211 ± 35% and 151 ± 42% at 2, 4, 6 and
18 h, respectively (n = 6–9), which was statistically signif-
icant at the 6-h time point (Fig 4b). At all time points, the
number of activated caspase-positive cells in the presence of
tBHQ (30 lM) and NMDA (50 lM) was lower than the
number of activated caspase-positive cells in the presence of
NMDA alone, and at 6 h, the tBHQ reduction of NMDA-
induced caspase activation was highly significant (40 ± 10%
of NMDA-treated numbers, n = 9). The phenolic antioxidant
tBHQ in its own right did not significantly decrease the
number of caspase-positive cells at any time point. We note
(b)(a)
(d)(c)
Fig. 3 Inhibition of FKHD-mediated gene
expression by tert-Butylhydroquinone
(tBHQ). Cortical neurones (8 DIV) were
transfected with pARE-luc (a, b) or FHRE-
luc (c, d) and then treated with, 10 lM or
30 lM tBHQ for 24 h (a and c) or 30 lM
tBHQ for different time periods as shown (b
and d). Data represent mean ± SEM,
analysed using one-way ANOVA and Bon-
ferroni post hoc test (n = 3, each concen-
tration performed in triplicate) where
*p < 0.05, **p < 0.01 ***p < 0.001 com-
pared to vehicle control.
 2012 The Authors
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that, in these experiments, longer incubation times resulted in
a time-dependent increase in the number of activated caspase
3-positive cells, even in the absence of any stimulation,
suggesting some cell death in these cultures. For example, at
18 h, the vehicle control cultures had 361 ± 85% (n = 9)
more caspase-positive cells compared with the vehicle
control cultures at 2 h. In parallel with induction of the
apoptotic marker, activated caspase 3, NMDA-induced
nuclear foxO3A (Fig. 4a). The NMDA-induced increase in
cells with nuclear foxO3A were 239 ± 27%, 188 ± 26%,
295 ± 32% and 312 ± 70% to the level in vehicle-treated
controls, at 2, 4, 6 and 18 h respectively (Fig 4c, n = 9). This
increase was statistically significant at all time points tested.
At all time points, tBHQ prevented the NMDA-induced
increase in foxo3A. Co-administration of tBHQ with NMDA
significantly reduced in the number of cells with nuclear
foxO3A to 51 ± 12%, 49 ± 16%, 39 ± 6% and 30 ± 6% to
the levels with NMDA alone at 2, 4, 6 and 18 h respectively
(Fig 4c, n = 6–9) tBHQ in its own right did not cause a
significant change in the number of cells with nuclear
foxO3A.
tBHQ opposes NMDA-induced increase in forkhead-
response element-activity and protects against NMDA-
evoked toxicity
We further tested if tBHQ opposed NMDA effects via
regulation of FHRE activity. Neurones were treated with
NMDA (50 lM; 6 h) in the presence and absence of tBHQ
(30 lM). NMDA increased FHRE activity consistent with
the observed increase in nuclear FoxO3a and this increase
was attenuated by co-treatment with tBHQ (30 lM) (Fig 5a).
We note that longer term exposure (24 h) to NMDA (50 lM)
induced neuronal loss, which confounded the luciferase
expression data. Short-term exposure (20 min) to NMDA
inhibited FHRE activity (data not shown), consistent with
previous reports of pre-conditioning-dependent neuroprotec-
tion (Soriano et al. 2006).
Finally, to determine whether tBHQ actions can confer
protection against excitotoxicity, neuronal viability was
examined following exposure to NMDA (3–300 lM, 24 h)
in the presence or absence of tBHQ (30 lM). Exposure
to NMDA caused concentration-dependent neuronal cell
damage as assessed by a reduction in MTT turnover.
(a)
(b) (c)
Fig. 4 NMDA induction of activated caspase is accompanied by
accumulation of nuclear FoxO3A and blocked by tert-Butylhydroqui-
none (tBHQ). (a) Representative photomicrograph showing cortical
neurones (8DIV) after 6-h treatment with 0.1% ethanol vehicle (C),
NMDA (50 lM) (N), tBHQ (30 lM) (T), or NMDA and tBHQ combined
(N + T). Top panel shows staining for activated caspase 3 (green),
and nuclear Hoe 33342 (blue). Bottom panel shows staining for fox-
O3A (green) and Hoe 33342 (blue), arrowheads indicate cells with
strongly foxo3A-positive nuclei. Scale bar = 10 lm. (b) shows quan-
tification of nuclei associated with activated caspase 3 at different time
points after application of 0.1% ethanol vehicle (C), NMDA (50 lM)
(N), tBHQ (30 lM) (T) or tBHQ and NMDA combined (T + N). (c)
shows quantification of foxO3A-positive nuclei after the same
treatments. In B + C, Bars show means and SEM derived from
counts of six to nine fields from three experiments. Analysis was by
ANOVA and Bonferroni’s multiple comparison test: *, **, *** = p < 0.05,
p < 0.01, p < 0.001 compared to vehicle control. #, ##, ### = p < 0.05,
p < 0.01, p < 0.001 compared to NMDA treatment only.
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Co-treatment with tBHQ significantly inhibited NMDA-
induced reduction in MTT turnover, consistent with tBHQ
eliciting a neuroprotective effect. (Fig 5b).
Discussion
FoxO3a activity is enhanced in neurones principally by a loss
of trophic support (Gilley et al. 2003), but here we have
shown that prolonged exposure of cortical neurones to
NMDA also appears to enhance nuclear accumulation of
FoxO3a. This is in general agreement with a recent report
that extrasynaptic NMDA receptor stimulation enhances
FoxO3a nuclear translocation in hippocampal neurones
(Dick and Bading 2010). Enhanced nuclear translocation of
FoxO3a is consistent with an NMDA-stimulated loss of PI3-
kinase-dependent phosphorylation of FoxO3a, which has
also been observed following exposure to high concentra-
tions of glutamate (Zheng and Quirion 2009). Here, we show
a correlation between NMDA-induced loss of FoxO3a
phosphorylation and FoxO3 nuclear localization, which is
reflected in an increase in FHRE-mediated gene expression,
induction of a pro-apoptotic protein known to be regulated
directly by FoxO proteins, FasL, and NMDA-induced cell
death. In contrast, calcium-signalling evoked by stimulation
of synaptic NMDA receptors has been shown to protect
against FoxO3a translocation (Dick and Bading 2010),
indeed, we observed inhibition of FHRE-mediated gene
expression upon short-term exposure to NMDA (not shown),
which is consistent with neuroprotective PI3-kinase-depen-
dent Akt signalling activity associated with acute activation
of this receptor population (Perkinton et al. 2002; Soriano
et al. 2006). It is likely, therefore, that the switch to increased
FHRE-mediated gene expression and pro-death signalling
observed following prolonged exposure to NMDA results
from down-regulation of the protective PI3-kinase-dependent
element of the pathway and recruitment of the extrasynaptic
NMDA receptor population in a similar manner to the well-
characterized CREB shut-off pathway (Hardingham and
Bading 2010).
As tBHQ as well as various dietary polyphenolics
stimulate PI3-kinase-dependent Akt phosphorylation and
up-regulate Nrf2-mediated antioxidant response element
activity (Kang et al. 2002; Kraft et al. 2004; Schroeter et al.
2007; Bahia et al. 2008; Arredondo et al. 2010), and tBHQ
has been reported to protect motor neurones against FasL-
induced neurodegeneration (Pehar et al. 2007), we consid-
ered that tBHQ might also suppress FoxO3a nuclear
translocation, which might underlie some of its neuropro-
tective efficacy. Accordingly, we found that tBHQ stimulated
PI3-kinase-dependent phosphorylation of FoxO3a in neuro-
nes and this correlated with its retention in the cytosol against
a basal low-level accumulation of FoxO3a in the nucleus.
Furthermore, tBHQ effectively suppressed NMDA-depen-
dent FoxO3a nuclear accumulation and FHRE activity,
attenuated NMDA-dependent activation of caspase 3 in
neurones and reduced NMDA-induced neuronal death.
Although these observations are strictly correlative, they
are strongly suggestive of a very close relationship between
regulation of FoxO3a activity and neuronal cell death and
identify tBHQ and compounds of this type, for example
dietary polyphenolic compounds, as potential suppressors of
FoxO-dependent cell death. Our findings have been carried
out in neuronal cultures with very few astrocytes present
(< 5%), suggesting that antioxidant signalling to prevent
(a)
(b)
Fig. 5 tert-Butylhydroquinone (tBHQ) opposes NMDA-induced up-
regulation of FKHD-mediated gene expression and protects against
NMDA-evoked neuronal damage. (a) Cortical neurones (8 DIV) were
transfected with FHRE-luc and were then treated with NMDA (50 lM;
6 h; ) or vehicle control (h) in the presence and absence of tBHQ
(30 lM). Data represent mean ± SEM, analysed using one-way ANOVA
and Bonferroni post hoc test (n = 3, each concentration performed in
triplicate). NMDA increased FHRE activity compared with vehicle
control *p < 0.05 and tBHQ inhibited FKHR compared to vehicle
control #p < 0.05. (b) Cultured cortical neurones (8 DIV) were incu-
bated with increasing concentrations of NMDA in the presence of
30 lM tBHQ ( ) or vehicle control ( ) for 24 h. Cell viability was as-
sessed using the MTT assay where the absorbance of reduced MTT
was read at 505 nm. Neurones co-treated with tBHQ were significantly
protected against 100 and 300 lM NMDA insults. Data represent
mean ± SEM, analysed using one-way ANOVA and the Bonferroni post
hoc test (n = 4) where **p < 0.01 for individual NMDA concentrations
versus control.
 2012 The Authors
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FoxO activation and neuronal death are mediated by
pathways intrinsic to neurones, nevertheless we cannot
completely exclude at this time that tBHQ is acting on
astrocytes to confer neuronal protection. The precise mech-
anisms underlying these protective effects are not yet clear,
but there is emerging evidence that deacetylation and
methylation regulate the stability and activity of FoxO3
(Wang et al. 2012). Most notably, oxidative stress-evoked
neuronal apoptosis is inhibited by Set9-mediated lysine
methylation of FoxO3 (Xie et al. 2012) and this therefore
represents a potential target for the protective actions of
tBHQ and dietary antioxidants.
Our study supports emerging data, which suggest that
FoxO3A is a key mediator of the progressive neuronal cell
loss associated with neurodegeneration and with other
disorders of the nervous system. For example, increased
FoxO3a has been found localized to Lewy bodies and Lewy
neurites in Parkinson’s disease brain tissue (Su et al. 2009)
and activation of FoxO by LRRK2, associated with autoso-
mal-dominant late-onset Parkinson’s disease, enhances neu-
ronal cell death in Drosophila (Kanao et al. 2010). With
respect to Alzheimer’s disease, inactivation of FoxO3a
activity is correlated with reduced Alzheimer’s disease-like
pathology and with preservation of spatial reference memory
in Tg2576 mice (Qin et al. 2008). This implies that APP
over-expression activates FoxO3a in brain regions associated
with spatial memory, which is consistent with the reduced
levels of Akt phosphorylation observed in the hippocampus
of APPswe mutant mice (Abbott et al. 2008). In motor
neurons, FoxO3a activity is thought to contribute to neuronal
cell death (Brunet et al. 1999; Barthelemy et al. 2004) and
similarly we interpret our observed increase in nuclear
FoxO3a in motor neurons as a contributing factor to
apoptosis; however, this is not consistent with findings
that stimulating FoxO3a activity is broadly neuroprotective
in C-elegans, Drosophila and in mouse motor neurons
(Mojsilovic-Petrovic et al. 2009). It is therefore possible that
the enhanced nuclear levels of FoxO3a observed in our
motor neurons represent a failed neuroprotective response.
Generally, differences in beneficial versus harmful effects of
FoxO3a are more likely to relate to cell-circumstance-
specific level of expression, activation and post-translational
modification (Mojsilovic-Petrovic et al. 2009).
On the basis of our data, we propose, therefore, that tBHQ
and perhaps other dietary polyphenolics, in addition to their
well-documented effects on antioxidant response element-
mediated gene expression, exert neuroprotection by regulat-
ing the localization and activity of FoxO3a, thereby opposing
apoptosis. In this context, we note that a number of
flavonoids are also capable of modestly reducing FHRE
activity (data not shown), suggesting that regulation of
nuclear translocation of FoxO3A might be a common feature
of molecules possessing antioxidant activity. Indeed, our data
predict that activation of the antioxidant response element is
accompanied by reciprocal regulation of FHRE. We do not
yet know if these observations are mechanistically related,
but hypoxic pre-conditioning which up-regulates an anti-
oxidant response protects against transient global ischaemia
by increasing FoxO phosphorylation (Zhan et al. 2010) and
signalling pathways linking oxidative stress to neuronal cell
death have previously been attributed to FoxO activation
(Lehtinen et al. 2006; Yuan et al. 2009), so the link between
these responses is compelling. In summary, our data support
a role for FoxO3a in NMDA-evoked neuronal apoptosis and
suggest that phenolic antioxidants such as tBHQ oppose
stress-induced activation of FoxO3a and therefore may have
potential neuroprotective utility in neurodegeneration.
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